C. Warren Olanow

5 ta ish

Icahn School of Medicine at Mount Sinai

1. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

   Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman +22

   Maqola20085 iqtibos

   ABIABI:AkademIndex/2026.other.653860

2. MDS clinical diagnostic criteria for Parkinson's disease

   Ronald B. Postuma, Daniela Berg, Matthew Stern +15

   Sharh maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.112643

3. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

   Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry +9

   Sharh maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.591762

4. Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder?

   C. Warren Olanow, Patrik Brundin

   Sharh maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.798521

5. Peripheral alpha‐synuclein and Parkinson's disease

   C. Warren Olanow, Dustin R. Wakeman, Jeffrey H. Kordower

   Tahririyat maqolasi20142 iqtibos

   ABIABI:AkademIndex/2026.other.798522